Atlas Trials

Staccato Loxapine Single Dose PK

Clinical trial NCT00444028 · COMPLETED

Trial details

NCT number
NCT00444028
Sponsor
Alexza Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Schizophrenia
Start date
2005-09-01
Primary completion
2005-11-01
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.